Back to News
Market Impact: 0.15
Bronstein, Gewirtz & Grossman LLC Urges Capricor Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Source: globenewswire.com
Legal & LitigationCompany Fundamentals
A class action lawsuit has been filed against Capricor Therapeutics (NASDAQ: CAPR) and certain officers. The news is a modest negative headline for equity risk, though no financial figures or guidance changes were provided in the article.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
CAPR-0.90
More News
- CAPR DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Capricor Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action
- CAPR Stock Skyrockets 144% in a Month: What Is Driving the Rally?
- Mistral bags $24 billion valuation as Samsung leads funding for Europe's AI champion
- Cholesterol drug setback casts doubt over multibillion-dollar race
- Bathla collapse, data center boom, Ingenia Communities
- Nvidia supplier Wistron's shares drop after it announces $1.5 billion global stock sale